For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development | 2,184,318 | 1,449,832.5* | 2,848,544 | 2,700,939 |
| General and administrative | 5,738,904 | 3,677,815.5* | 3,147,291 | 1,949,035 |
| Operating loss | -7,923,222 | -5,127,648* | -5,995,835 | -4,649,974 |
| Issuance cost and change in fair value of derivative | - | -1,165,834* | 772,169 | - |
| Change in fair value of derivative | 852,030 | - | - | - |
| Interest and other income (expense), net | -536,837 | -293,401.5* | -573,058 | -138,761 |
| Loss before income taxes | -9,312,089 | -4,255,215.5 | -7,341,062 | -4,788,735 |
| Income tax benefit (expense) | - | - | - | 0 |
| Net loss and comprehensive loss | -9,312,089 | -4,255,215.5 | -7,341,062 | -4,788,735 |
| Basic EPS | -0.95 | -0.796 | -1.35 | -1.09 |
| Diluted EPS | -0.95 | -0.796 | -1.35 | -1.09 |
| Basic Average Shares | 9,777,786 | 5,345,316 | 5,431,206 | 4,389,465 |
| Diluted Average Shares | 9,777,786 | 5,345,316 | 5,431,206 | 4,389,465 |
Cingulate Inc. (CINGW)
Cingulate Inc. (CINGW)